News & Press
Omniscient Neurotechnology partners with Johns Hopkins for connectome-guided DBS across 500 patients
Johns Hopkins Medicine News3/19/2026·03/19/26🌐 USA
Summary
Omniscient Neurotechnology announced a 3-year research partnership with Johns Hopkins Hospital to use their qEEG connectome mapping platform for DBS surgical planning in 500 patients across Parkinson's, dystonia, OCD, and treatment-resistant depression. Results will form the largest connectome-guided DBS outcomes dataset ever assembled.
Why it matters
A 500-patient connectome-guided DBS study at one of the world's top neurosurgery centers will generate the outcomes evidence needed for connectome planning to become standard of care. Johns Hopkins' international reputation means these results will influence DBS practice globally.
#AI Diagnostics#Australia#Deep Brain Stimulation#Neuroimaging
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in